Bonne Biesma

9.6k citations
96 papers · 6.5k · 2 hit papers · h-index 34

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
  • Oncology top 0.5%
    • Lung Cancer Research Studies
    • Neutropenia and Cancer Infections
    • Colorectal Cancer Treatments and Studies

Papers in

    • Lung Cancer Treatments and Mutations 45
    • Lung Cancer Diagnosis and Treatment 23
    • Occupational and environmental lung diseases 5
    • Lung Cancer Research Studies 35
    • Neutropenia and Cancer Infections 13

Bonne Biesma

93 papers receiving 6.4k citations

Bonne Biesma's Hit Papers

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer 2008 · 2.5k citations
2.5k0+6+12Years since publication50010001.5k2.0k

Peers

Bonne Biesma
Comparison fields: 5 of 120
  • Pulmonary and Respiratory Medicine 3.5k
  • Oncology 2.9k
  • Cancer Research 484
  • Otorhinolaryngology 78
  • Hematology 208
Replace Philip Bonomi with:
Philip Bonomi United States
Rogério Lilenbaum United States
Petr Zatloukal Czechia
Charles Butts Canada
Rafat Ansari United States
Antonius A. Miller United States
Nick Thatcher United Kingdom
Nobuyuki Katakami Japan
Wayne L. Hofstetter United States
Arnoud J. Templeton Switzerland
Bonne Biesma relative to Philip Bonomi United States Philip Bonomi's profile →
Citations per field
00.5×1.5×2.0×
Philip Bonomi · 1×
Citations per year

Countries citing papers authored by Bonne Biesma

Since Specialization
Citations

This map shows the geographic impact of Bonne Biesma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bonne Biesma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bonne Biesma more than expected).

Fields of papers citing papers by Bonne Biesma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bonne Biesma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bonne Biesma. The network helps show where Bonne Biesma may publish in the future.

Co-authors

The 25 scholars most cited alongside Bonne Biesma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bonne Biesma Line = papers co-authored together Bonne Biesma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
Hit paper breakdown →
20082493
2
Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer
Hit paper breakdown →
2007474
3 2010338
4 2003280
5 2005204
6 2012197
7 2006152
8 1998137
9 2005128
10 2009116
11 200996
12 199991
13 201186
14 201180
15 200179
16
A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma.
199178
17 200275
18 199471
19 199268
20 199265

About Bonne Biesma

Bonne Biesma is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Molecular Biology and Cancer Research, having authored 96 papers that have together received 6.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (45 papers), Lung Cancer Research Studies (35 papers), Lung Cancer Diagnosis and Treatment (23 papers), Neutropenia and Cancer Infections (13 papers), Neuroendocrine Tumor Research Advances (7 papers), Occupational and environmental lung diseases (5 papers), Cancer therapeutics and mechanisms (5 papers) and Neuroblastoma Research and Treatments (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.5k citations), Oncology (2.9k citations), Cancer Research (484 citations), Otorhinolaryngology (78 citations) and Hematology (208 citations). Bonne Biesma has collaborated with scholars based in Netherlands, Belgium and Germany. Frequent co-authors include Egbert F. Smit, Joachim von Pawel, Johan Vansteenkiste, Giorgio V. Scagliotti, Filippo de Marinis, Keunchil Park, Christian Manegold, Katherine P. Sugarman, Lorinda Simms and David R. Gandara. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Annals of Oncology, Journal of Thoracic Oncology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact